.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chubb
Julphar
Healthtrust
Novartis
Cerilliant
Harvard Business School
UBS
Medtronic
Deloitte

Generated: June 28, 2017

DrugPatentWatch Database Preview

PROPOXYPHENE HYDROCHLORIDE 65 Drug Profile

« Back to Dashboard

What is the patent landscape for Propoxyphene Hydrochloride 65, and what generic Propoxyphene Hydrochloride 65 alternatives are available?

Propoxyphene Hydrochloride 65 is a drug marketed by Warner Chilcott and is included in one NDA.

The generic ingredient in PROPOXYPHENE HYDROCHLORIDE 65 is propoxyphene hydrochloride. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the propoxyphene hydrochloride profile page.

Summary for Tradename: PROPOXYPHENE HYDROCHLORIDE 65

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list10
Clinical Trials: see list2,247
Patent Applications: see list5,427
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROPOXYPHENE HYDROCHLORIDE 65 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott
PROPOXYPHENE HYDROCHLORIDE 65
propoxyphene hydrochloride
CAPSULE;ORAL083786-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Healthtrust
Chubb
Covington
US Army
Chinese Patent Office
QuintilesIMS
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot